Related Experiment Video
Updated: Aug 7, 2026
03:26
Detrusor Underactivity Model in Rats by Conus Medullaris Transection
Published on: August 28, 2020
Overactive bladder syndrome: considerations in pharmacotherapy and new perspectives
Stefano Salvatore1, Maurizio Serati, Matteo Zanfrà
1Clinica Ostetrica e Ginecologica, Insubria University, Varese, Italy. stefanosalvatore@hotmail.com
Gynakologisch-Geburtshilfliche Rundschau
|June 17, 2006
Summary
Overactive bladder (OAB) affects many women, impacting quality of life. Alpha-adrenolytic drugs show promise for OAB treatment, with research exploring adrenoceptor subtypes in the female lower urinary tract.
Area of Science:
- Urology
- Pharmacology
Background:
- Overactive bladder (OAB) syndrome has significant epidemiological relevance and impacts patient quality of life.
- Pharmacological treatments for OAB are under extensive investigation in both basic and clinical research.
Purpose of the Study:
- To review current pharmacological treatments for female lower urinary tract disorders.
- To explore new therapeutic perspectives for OAB using alpha-adrenolytic drugs.
- To discuss findings related to adrenoceptor subtypes in the female lower urinary tract.
Main Methods:
- Survey of female lower urinary tract disorders.
- Review of current pharmacological treatments.
- Analysis of recent studies on adrenoceptor subtypes.
Main Results:
- Identification of various adrenoceptor subtypes in the female lower urinary tract.
- Anecdotal data suggests potential efficacy of alpha-adrenolytic drugs for OAB.
Conclusions:
- Alpha-adrenolytic drugs represent a novel therapeutic avenue for overactive bladder syndrome.
- Further research into adrenoceptor subtypes may refine OAB treatment strategies.
Related Concept Videos
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:17Urinary Tract Infection IV: Nursing Management
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...